OXT and Hyperbilirubinemia: High-dose oxytocin significantly increased the risk of neonatal hyperbilirubinemia (odds ratio [OR] 7.933, 95% confidence interval [CI] 2.923–21.527, p < 0.001), while the moderate-dose group also showed an elevated risk (OR 3.034, 95% CI 1.059–8.692, p = 0.039).